Incidence rate and risk factors for hypoglycemia among individuals with type 1 diabetes or type 2 diabetes in China receiving insulin treatment

• Published in: Diabetes research and clinical practice Vol. 206; p. 110987
• Main Authors: Chen, Si, Lu, Jingyi, Peng, Danfeng, Liu, Fengjing, Lu, Wei, Zhu, Wei, Bao, Yuqian, Zhou, Jian, Jia, Weiping
• Format: Journal Article
• Language: English
• Published: Ireland 01.12.2023
• Subjects: Adult; China - epidemiology; Diabetes Mellitus, Type 1 - drug therapy; Diabetes Mellitus, Type 1 - epidemiology; Diabetes Mellitus, Type 2 - epidemiology; Humans; Hypoglycemia - chemically induced; Hypoglycemia - drug therapy; Hypoglycemia - epidemiology; Hypoglycemic Agents - adverse effects; Incidence; Insulin - adverse effects; Insulin, Regular, Human - therapeutic use; Risk Factors; China; Diabetes; Hypoglycemia; Application; Insulin; Mobile health
• ISSN: 0168-8227; 1872-8227
• DOI: 10.1016/j.diabres.2023.110987

We investigated the real-world incidence of hypoglycemic events among patients with type 1 or type 2 diabetes (T1DM or T2DM) receiving insulin in routine clinical practice in China. In this observational study, data were collected electronically via the Lilly Connected Care Program (LCCP) electronic system from adults with T1DM or T2DM who had registered on LCCP between 1 February 2019 and 31 January 2022, had used insulin for a full 12-week period following registration. The following outcomes were assessed during the 12 weeks following registration: incidence of level 1 and level 2 hypoglycemia. In total, 22,752 patients were enrolled. Among patients with monitoring data, over the 12-week study period, level 1 and 2 hypoglycemia were experienced by 48.8% and 25.9% of patients with T1DM and 26.5% and 13.9% of patients with T2DM. The proportion of patients treated with oral anti-diabetes drugs (OADs) capable of producing hypoglycemia (sulfonylurea or glinide) was 1.3% in T1DM and 1.6% in T2DM, respectively. Questionnaire data revealed that up to 92.5% of hypoglycemic events occurred outside of hospital and 18.6% were serious. These real-world data collected from Chinese patients with diabetes receiving insulin treatment reveal a relatively high percentage of patients experiencing hypoglycemia, with around one quarter of these events classified as severe and as many as 92.5% occurring outside of a hospital or clinic.